NEWS

26 March 2013

Another success for the TRANSVAC training course 2013 on "Practical approaches to vaccine development"

The second TRANSVAC training course on “Practical approaches to vaccine development” was held on 11-15 March 2013 at the Vaccine Formulation Laboratory (VFL) training center, University of Lausanne, Switzerland. Read the Post-training advert to learn more about the course agenda and the feedbacks from the participants.

06 March 2013

TRANSVAC Annual Meeting 2013

The TRANSVAC Annual Meeting will be held on 7-8 March 2013 at the Internationales Wissenschaftsforum der Universität Heidelberg, Heidelberg, Germany.

04 March 2013

Workshop on Global Analysis Platforms for HIV, TB and Malaria

The workshop will be held on 6 March 2013 at the Internationales Wissenschaftsforum der Universität Heidelberg, Heidelberg, Germany.

25 February 2013

Symposium on Animal models for infectious diseases: state of the art and challenges

The Symposium will take place at Fontenay-aux-Roses, France, on Friday 24 May 2013.
No registration fee is requested. Participation is on "first come first served basis".

19 February 2013

Stakeholders celebrate 15th anniversary of European Vaccine Initiative

European Vaccine Initiative marks 15th anniversary with symposium on global health and diseases of poverty.

07 February 2013

Recent Publication of Results from MVVC-funded Research Studies

Three new papers have recently been published in scientific journals on research conducted by the MVVC-funded postdoc Francis Ndungu and collaborators.

30 January 2013

EVI 15th Anniversary Symposium

EVI is pleased to announce a symposium on global health issues under the Patronage of the Minister for Science, Research and Art, Baden Württemberg, that will take place in Heidelberg, 26 February 2013 on the occasion of EVI´s 15th Anniversary. The agenda is available.

15 January 2013

Short course: Epidemiological Evaluation of Vaccines: Efficacy, Safety and Policy (LSHTM)

The overall aim of this short course is to provide an understanding of the methods used in the evaluation of vaccines, from early human trials through to assessment of population impact and policy. 

19 December 2012

Two EDCTP grants awarded to EVI

1. MVVC 2 (Malaria Vectored Vaccines Consortium 2): Field Trials of a New Combination Malaria Vaccine in West African Adults and Children

2. P27A CTb (P27A Phase Ib Clinical Trial)

Please open news item for details

21 November 2012

EVI Press Release on the interim results of the recent RTS, S phase III efficacy trial

The European Vaccine Initiative urges continued and sustainable malaria vaccine development efforts and funding.

Press release